Advertisement

Arbutus Biopharma Corporation ABUS

Set alert

Price alert · ABUS

All alert types
4.00 USD -0.21 -4.99%

At close · Nov 2

3.96 -0.04 -1.00%

After hours · Nov 2, 5:40 PM ET

Bid
3.99 × 2
Ask
4.00 × 2
3.99 Day range 4.29
3.50 52-week range 5.45
YTD
-16.84%
1 year
-15.43%
Open
4.22
Prev close
4.21
Mkt cap
613.10M
Vol
2.65M
Avg vol
4.91M
EPS
0.79
P/E
5.06
Div yield
0.00%
More statistics
Low
3.99
High
4.29
Forward P/E
-30.67
Beta
0.62
Short ratio
5.03
Inst. own
72.71%
Dividend
0.00
Ex-div date
Earnings
Nov 16, 2026
50-d avg
4.79
200-d avg
4.52
1y target
5.46

MAX chart

Chart tools
Interval

Chart is warming up

The all-time price history for ABUS has not been loaded yet. Try again in a moment.

Revenue & Expenses

Other Income → Expenses: $821.00KExpenses → Selling, General & Admin: $3.87MExpenses → Research & Development: $2.90MExpenses → Other Operating Expenses: $213.00KGross Profit → Expenses: $1.01MRevenue → Gross Profit: $1.01MNet Loss → Expenses: $5.14MOther Income$821.00KGross Profit$1.01MNet Loss$5.14MExpenses$6.98MSelling, General & Admin$3.87MResearch & Development$2.90MOther Operating Expenses$213.00KRevenue$1.01M

Period ending Jun 30, 2026 · select a line to chart its history

Income statement

ABUS quarterly income statement
1.01M
1.01M
1.01M
6.76M
2.90M
3.87M
-5.75M
18.00K
-5.14M
-5.14M
-5.14M
-5.14M
-0.03
-0.03
-0.03
-5.13M
-5.13M
197.47M
197.47M

Balance sheet

ABUS quarterly balance sheet
19.17M
19.17M
73.45M
73.45M
179.74M
273.88M
10.00K
274.02M
514.00K
3.63M
3.36M
3.11M
15.29M
-1.22B
-48.24M
258.73M
258.73M
142.00K
3.63M
11.93M
2.85M

Cash flow

ABUS quarterly cash flow
11.00K
3.15M
-4.54M
3.15M
-1.66M
-1.66M
-6.02M
-4.00K
1.63M
Advertisement